🔥The 9th Round of Easy Loan, Earn $40 Reward is in progress❗️ ⏰ Promotion Period: January 15th - Feburary 15th, 2025 👉 Register now and check more details at gate.io/campaigns/358

Looking for a motivated and talented PhD student: Are you passionate about experimental/computational immunology and cancer biology? Join our team at TranslaTUM!🌟linkedin.com/jobs/view/4079… TU München TranslaTUM #PhDOpportunity #CancerResearch #Immunology #SystemsBiology

Online Now: Plasma cell and cancer stem cell crosstalk in glioblastoma dlvr.it/TH8rGC

Excited to share our latest in Nature Medicine✨ We present a detailed clinico-genomic landscape of pancreatic adenocarcinomas With important implications for RAS 🎯 therapies Expertly co-led by Anna Varghese and Maria A Perry. w/Eileen M O’Reilly & colleagues Memorial Sloan Kettering Cancer Center

I am pleased to announce our latest review article published in Trends in Cancer ! In this review, we summarize recent advances in myeloid-oriented therapeutics for cancer. Myeloid cell modulation is a growing frontier in cancer therapy. authors.elsevier.com/a/1kPgF8Z12yXj…

New Nature Cancer paper from Rosie Sears LisaCoussens@CoussensLab and colleagues OHSU Knight Cancer Institute address the clinical question of why patients with #PancreaticCancer associated with lung only metastatic disease have a better prognosis than liver metastases. The answer lies in the ability to

#ScienceSaturday ➡️ How does the history of T cells impact their ability to fight #cancer when engineered with chimeric antigen receptors? ➡️ In this study, DeGolier, et al. found that many traits of the ancestral T cells remained in final CAR T cell populations, including

We are so excited to see the innovative science at Keystone Symposia's Cancer Immunotherapy: Clinical Lessons to New Modalities! Poster abstract submissions and early registration are still open! Register today: hubs.li/Q030-Ph30 #KSCancerImmune25

#OpenAccess review in Trends in Cancer by Jakob Nikolas Kather & team highlights how AI-derived biomarkers can streamline personalized #oncology . Large-scale validation and equitable access remain key challenges. #PrecisionMedicine OncoAlert 🚨 cell.com/trends/cancer/…

🔥Trends in Cancer🆙 ✅Turning cold into hot: emerging strategies to fire up the tumor microenvironment 🎯Summary of the intrinsic, extrinsic, and systemic factors developing ‘cold’ tumors 👥Dr. Kaili Ma #LCSM OncoAlert #ICI cell.com/trends/cancer/…

👀Tumor cells promotes TIL dysfunction through transfer of dysfunctional mitochondria👀 Fascinating new mechanism for tumor-induced T cell dysfunction in nature today. Interesting parallels to recent paper by the Gattinoni Lab. rdcu.be/d687T

#ScienceSaturday ❓ What is the "obesity paradox" in cancer #immunotherapy? ➡️ Although obesity increases the risk of #cancer, it's also been linked with better outcomes for some patients treated with immune checkpoint inhibitors (ICIs), a type of immunotherapy. ➡️ In this

Join the discussion: Pervasive Cellular Plasticity intertwined with Darwinian Evolution in Cancer - does this need a new Evolutionary Theory? See our review just out in Trends in Cancer sciencedirect.com/science/articl…

Online Now: Microglial reprogramming enhances antitumor immunity and immunotherapy response in melanoma brain metastases dlvr.it/THrTTS

🧵1/Cancer isn’t just about uncontrolled cell growth. It’s a systemic disease. A new review highlights an often-overlooked player in tumor progression: pain-sensing neurons. Let’s talk about why this matters for #metastasis and #cancer therapy #Neuroscience #oncology #Immuno #NIH

Deciphering immune predictors of immunotherapy response: A multiomics approach at the pan-cancer level Cell Reports Medicine cell.com/cell-reports-m…

Online Now: Epigenomic State Transitions Characterize Tumor Progression in Mouse Lung Adenocarcinoma dlvr.it/TJP2rr

Learn more about the evolutionary dynamics of the #liver immune landscape in this new review, written by Drs. Christel Ramirez and Leila Akkari. They highlight exploitable immunomodulatory avenues amenable to mitigate #HCC. 📖 bit.ly/43tIUC1 | Trends in Cancer

Fantastic review on metastatic organotropism from Herbert Irving Comprehensive Cancer Center team (Anil K. Rustgi et al), discussing mediators & regulators of lung, liver, brain and bone organotropic metastases. #OpenAccess in Trends in Cancer

I was happy to contribute to TrendsTalk Trends in Cancer on Navigating Life as an ECR, specifically during challenging times cell.com/trends/cancer/…

Our recent review regarding the roles of eosinophils in cancer and cancer immunotherapy is online now in Trends in Cancer It was great writing this piece with Sharon Grisaru and X-less Beth Jacobsen! sciencedirect.com/science/articl… International Eosinophil Society Israel Cancer Research Fund